Revvity Inc
RVTY96.200USD
-0.060-0.06%
Handelsschluss 12/19, 16:00（ET）Kurse um 15 Minuten verzögert
10.97BMarktkapitalisierung
48.35KGV TTM
mehr Informationen über Revvity Inc Unternehmen
Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Revvity Inc Informationen
BörsenkürzelRVTY
Name des UnternehmensRevvity Inc
IPO-datumAug 12, 2101
CEOSingh (Prahlad R)
Anzahl der mitarbeiter11000
WertpapierartOrdinary Share
GeschäftsjahresendeAug 12
Addresse77 4Th Avenue
StadtWALTHAM
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl02451
Telefon17816636900
Websitehttps://www.revvity.com/
BörsenkürzelRVTY
IPO-datumAug 12, 2101
CEOSingh (Prahlad R)
Führungskräfte von Revvity Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
96.84K
-8.87%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+6.67%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+10.22%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
22.80K
-2.39%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+61.74%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
13.71K
+21.36%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
10.44K
-53.85%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Independent Director
Independent Director
5.09K
+90.13%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
5.09K
+90.13%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
96.84K
-8.87%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+6.67%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+10.22%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
22.80K
-2.39%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+61.74%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Product
610.70M
84.79%
Service
109.58M
15.21%
Nach RegionUSD
Name
Umsatz
Anteil
Americas
323.58M
44.92%
Europe
203.63M
28.27%
Asia
193.07M
26.80%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Product
610.70M
84.79%
Service
109.58M
15.21%
Aktionärsstatistik
Aktualisiert: Mon, Nov 17
Aktualisiert: Mon, Nov 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
T. Rowe Price Investment Management, Inc.
19.85%
The Vanguard Group, Inc.
11.88%
EdgePoint Investment Group Inc.
7.56%
T. Rowe Price Associates, Inc.
7.05%
Janus Henderson Investors
6.73%
Andere
46.93%
Aktionäre
Aktionäre
Anteil
T. Rowe Price Investment Management, Inc.
19.85%
The Vanguard Group, Inc.
11.88%
EdgePoint Investment Group Inc.
7.56%
T. Rowe Price Associates, Inc.
7.05%
Janus Henderson Investors
6.73%
Andere
46.93%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
70.04%
Investment Advisor/Hedge Fund
25.98%
Hedge Fund
2.79%
Pension Fund
1.77%
Research Firm
1.69%
Sovereign Wealth Fund
1.18%
Bank and Trust
1.07%
Individual Investor
0.30%
Family Office
0.05%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
1177
117.06M
100.85%
-8.83M
2025Q2
1199
113.79M
98.03%
-7.04M
2025Q1
1255
117.73M
99.83%
-3.82M
2024Q4
1277
114.54M
95.28%
-3.97M
2024Q3
1253
112.35M
91.11%
-5.77M
2024Q2
1249
112.44M
91.13%
-1.63M
2024Q1
1287
107.57M
87.09%
-8.24M
2023Q4
1315
109.29M
88.55%
-2.41M
2023Q3
1347
106.10M
85.47%
-6.10M
2023Q2
1383
106.88M
85.21%
-9.65M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
T. Rowe Price Investment Management, Inc.
22.64M
19.51%
+126.19K
+0.56%
Jun 30, 2025
The Vanguard Group, Inc.
14.03M
12.09%
-297.65K
-2.08%
Jun 30, 2025
EdgePoint Investment Group Inc.
6.79M
5.85%
+1.43M
+26.65%
Jun 30, 2025
T. Rowe Price Associates, Inc.
7.80M
6.72%
-1.59M
-16.90%
Jun 30, 2025
Janus Henderson Investors
7.22M
6.22%
+1.23M
+20.47%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.81M
5%
-259.62K
-4.28%
Jun 30, 2025
State Street Investment Management (US)
5.02M
4.32%
-150.58K
-2.91%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.98M
2.56%
-18.52K
-0.62%
Jun 30, 2025
Invesco Capital Management LLC
1.94M
1.67%
+422.41K
+27.88%
Jun 30, 2025
UBS Financial Services, Inc.
1.75M
1.51%
+1.12M
+178.25%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
First Trust Indxx Medical Devices ETF
2.12%
Invesco S&P 500 Equal Weight Health Care ETF
1.85%
T Rowe Price Capital Appreciation Equity ETF
1.36%
Simplify Health Care ETF
1.29%
ROBO Global Healthcare Technology & Innovation ETF
1.16%
First Trust Health Care Alphadex Fund
0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.84%
VanEck Morningstar SMID Moat ETF
0.64%
Neuberger Berman Small-Mid Cap ETF
0.56%
NYLI Candriam US Mid Cap Equity ETF
0.5%
Mehr Anzeigen
First Trust Indxx Medical Devices ETF
Anteil2.12%
Invesco S&P 500 Equal Weight Health Care ETF
Anteil1.85%
T Rowe Price Capital Appreciation Equity ETF
Anteil1.36%
Simplify Health Care ETF
Anteil1.29%
ROBO Global Healthcare Technology & Innovation ETF
Anteil1.16%
First Trust Health Care Alphadex Fund
Anteil0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
Anteil0.84%
VanEck Morningstar SMID Moat ETF
Anteil0.64%
Neuberger Berman Small-Mid Cap ETF
Anteil0.56%
NYLI Candriam US Mid Cap Equity ETF
Anteil0.5%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
168.35M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Oct 23, 2025
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 06, 2026 going ex on Jan 16, 2026
Jan 16, 2026
Feb 06, 2026
Jan 16, 2026
Jul 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Nov 07, 2025 going ex on Oct 17, 2025
Oct 17, 2025
Nov 07, 2025
Oct 17, 2025
Apr 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 08, 2025 going ex on Jul 18, 2025
Jul 18, 2025
Aug 08, 2025
Jul 18, 2025
Jan 23, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 09, 2025 going ex on Apr 17, 2025
Apr 18, 2025
May 09, 2025
Apr 17, 2025
Oct 24, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025
Jan 17, 2025
Feb 07, 2025
Jan 17, 2025
Jul 25, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 08, 2024
Oct 18, 2024
Apr 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 09, 2024
Jul 19, 2024
Jan 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 10, 2024
Apr 18, 2024
Oct 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Feb 09, 2024
Jan 18, 2024
Jul 21, 2023
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 10, 2023
Oct 19, 2023
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Revvity Inc?
Die fünf größten Anteilseigner von Revvity Inc sind:
T. Rowe Price Investment Management, Inc. hält 22.64M Aktien, was 19.51% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 14.03M Aktien, was 12.09% der Gesamtaktien entspricht.
EdgePoint Investment Group Inc. hält 6.79M Aktien, was 5.85% der Gesamtaktien entspricht.
T. Rowe Price Associates, Inc. hält 7.80M Aktien, was 6.72% der Gesamtaktien entspricht.
Janus Henderson Investors hält 7.22M Aktien, was 6.22% der Gesamtaktien entspricht.
T. Rowe Price Investment Management, Inc. hält 22.64M Aktien, was 19.51% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 14.03M Aktien, was 12.09% der Gesamtaktien entspricht.
EdgePoint Investment Group Inc. hält 6.79M Aktien, was 5.85% der Gesamtaktien entspricht.
T. Rowe Price Associates, Inc. hält 7.80M Aktien, was 6.72% der Gesamtaktien entspricht.
Janus Henderson Investors hält 7.22M Aktien, was 6.22% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Revvity Inc?
Die drei wichtigsten Anteilseigner-Typen von Revvity Inc sind:
T. Rowe Price Investment Management, Inc.
The Vanguard Group, Inc.
EdgePoint Investment Group Inc.
T. Rowe Price Investment Management, Inc.
The Vanguard Group, Inc.
EdgePoint Investment Group Inc.
Wie viele Institutionen halten Anteile an Revvity Inc (RVTY)?
Mit Stand vom 2025Q3 halten 1177 Institutionen Anteile an Revvity Inc, mit einem Gesamtmarktwert von etwa 117.06M, was 100.85% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um 2.82% gestiegen.
Was ist die größte Einnahmequelle von Revvity Inc?
Am FY2025Q2 erzielte das Geschäft mit Product für Revvity Inc den höchsten Umsatz in Höhe von 610.70M, was 84.79% des Gesamtumsatzes entspricht.
